Prognostic value of bone marrow MUC4 expression in acute myeloid leukaemia
Abdelhady, A S; Abdel Hamid, F.F.; Hassan, N M; Ibrahim, Doaa;
Abstract
Background: Aberrant expression of mucin-4 (MUC4) is present in a variety of solid cancers, but the expression pattern of MUC4 and its clinical relevance in acute myeloid leukaemia (AML) is unknown. We aimed to evaluate the expression level of MUC4 and explore its prognostic value in newly diagnosed adult patients with AML. Methods: Bone marrow from 70 AML patients and 26 healthy donors was obtained. MUC4 levels were quantified by quantitative real-time PCR. Routine blood indices were measured by standard techniques. Results: Bone marrow MUC4 expression levels were significantly elevated in AML patients compared to controls at median (range) 2.77 (0.7-16.6) and 1.14 (0.5-1.99) respectively (p = 0.005). Moreover, lower MUC4 expression was strongly associated with persistent remission (p = 0.001) while higher MUC4 levels were associated with worse overall as well as disease-free survival (p = 0.011 and p = 0.006, respectively). Thus, its level may act as an indicator of disease progression. High MUC4 expression was identified as an independent prognostic predictor for both overall survival and disease-free survival. Conclusion:MUC4 over-expression is an independent predictor of a poor prognosis in AML patients.
Other data
Title | Prognostic value of bone marrow MUC4 expression in acute myeloid leukaemia | Authors | Abdelhady, A S; Abdel Hamid, F.F. ; Hassan, N M; Ibrahim, Doaa | Keywords | MUC4; Acute myeloid leukaemia; prognosis | Issue Date | Oct-2020 | Publisher | TAYLOR & FRANCIS LTD | Journal | British journal of biomedical science | ISSN | 0967-4845 | DOI | 10.1080/09674845.2020.1754583 | PubMed ID | 32270747 | Scopus ID | 2-s2.0-85085479979 | Web of science ID | WOS:000534172900001 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.